Understanding chronic pain and its impact

Chronic pain — pain that persists or recurs for three months or longer — affects an estimated 51.6 million U.S. adults, about one in five, according to the CDC.^[2] It takes many forms: nociceptive pain from tissue damage such as arthritis or back injury, neuropathic pain from nerve damage such as diabetic neuropathy or sciatica, and conditions like fibromyalgia where the nervous system itself amplifies pain signals. Beyond the pain itself, it erodes sleep, mood, mobility, and the ability to work — roughly 17 million Americans experience high-impact chronic pain that limits daily life.

Most patients start with conventional care: NSAIDs, physical therapy, nerve blocks, antidepressants or anticonvulsants for nerve pain, and in some cases opioids. Treatment responses vary widely, and many patients cycle through several approaches before finding durable relief.

When chronic pain continues despite treatment

Patients may experience partial relief, side effects that limit dosing — NSAIDs carry stomach and kidney risks with long-term use — or growing tolerance and dependence concerns with opioid therapy. When pain persists despite conventional treatment, patients and providers may discuss additional approaches. Medical cannabis enters those conversations not as a replacement but as a potential adjunct option within a supervised medical framework — and several states now explicitly recognize it as an alternative to opioid therapy.

How cannabis may help chronic pain

Cannabis interacts with the endocannabinoid system (ECS), which helps regulate pain signaling, inflammation, and immune response. The National Academies of Sciences reviewed the evidence and concluded there is conclusive or substantial evidence that cannabis is effective for the treatment of chronic pain in adults — one of the strongest ratings it gave any medical use.^[1] Two primary compounds behave differently:

• THC (Tetrahydrocannabinol): Activates CB1 receptors in the central nervous system, dampening pain signaling and easing the muscle tension and sleep loss that often accompany chronic pain. Dosing is individual — lower doses are typically better tolerated.^[4]
• CBD (Cannabidiol): A non-intoxicating compound with anti-inflammatory activity, acting through CB2 receptors on immune cells and other targets involved in pain and inflammation. Often used in balanced CBD:THC ratios for daytime relief.^[5]

Some studies also report that chronic pain patients using medical cannabis reduce their opioid use, though findings vary and any medication change should happen under medical supervision.^[3] Dose, ratio, and delivery method matter significantly — medical guidance helps patients match them to their specific pain presentation.

Choosing cannabis products for chronic pain

Rather than strain names, clinical importance centers on cannabinoid profile, delivery method, and timing.

• Topicals (localized, non-intoxicating): Creams and balms applied directly to joints or muscles — a common starting point for localized musculoskeletal pain.
• Sublingual tinctures (onset 15–45 min, duration 4–6 hrs): Precise titration; useful for steady daytime relief.
• Oral edibles/capsules (onset 45–120 min, duration 6–8 hrs): Longest-lasting option — suited to all-day or overnight pain control.
• Vaporized flower (onset 5–15 min, duration 2–3 hrs): Fastest relief for breakthrough pain; shorter duration.
• CBD:THC ratios: Balanced or CBD-dominant ratios provide anti-inflammatory support with less intoxication — often preferred for daytime function.

Responses vary from person to person, which is why individualized medical guidance is recommended before starting cannabis for chronic pain. For a closer look at specific cultivars patients discuss, see our guide to the best strains for chronic pain.

Chronic pain and medical marijuana eligibility by state

Chronic pain qualifies for a medical marijuana card by name in 29 states plus Puerto Rico — more than any other condition — though the wording varies: some list “chronic pain” outright, while others require “intractable” pain or pain that has resisted treatment for months. In about nine more jurisdictions, severe pain from a chronic or debilitating condition qualifies through a symptom clause, and six no-list jurisdictions leave certification to provider discretion. Massachusetts is the only program state where pain isn’t listed at all — patients there qualify through the provider catch-all.

Note: Qualifying conditions change; confirm current rules during your Leafwell evaluation. States without active medical programs (Idaho, Indiana, Kansas, North Carolina, South Carolina, Tennessee, Wisconsin, Wyoming; Nebraska’s program is still being implemented) are not listed.

How patients with chronic pain access medical cannabis

1. Medical evaluation — A licensed provider reviews your pain diagnosis, treatment history, and current medications to determine if medical cannabis is appropriate.
2. Certification if appropriate — If the provider determines cannabis may be beneficial, they issue certification under your state’s medical marijuana program.
3. State registration — Patients complete registration with their state’s health department to obtain the medical marijuana ID card.
4. Access regulated products — Once approved, patients purchase lab-tested cannabis from licensed dispensaries with clearly labeled THC and CBD levels.

Frequently asked questions